Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents

Details for Australian Patent Application No. 2005214371 (hide)

Owner Metabolex, Inc.

Inventors Sun, Hongbin; Wang, Jianchao; Liang, Jack Shih-Chieh; Chen, Xin; Zhao, Zuchun

Agent Pizzeys

Pub. Number AU-A-2005214371

PCT Pub. Number WO2005/080340

Priority 60/545,850 18.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 213/02 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 257/02 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080340 Priority application(s): WO2005/080340

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214372-Carton for multiple articles

2005214369-Sulfur-containing compositions and processes for making same